Plain-English translation of NCT06661655 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new, portable ultrasound device called Hepatoscope to measure how much fat has built up in your liver. The device uses sound waves to assess liver health non-invasively, meaning without any needles or surgery. Researchers will compare how well this new device works compared to other standard imaging methods like MRI and a technique called FibroScan.
Many people develop fatty liver disease related to metabolic problems like obesity or diabetes, and doctors need better, easier ways to monitor how much fat is in the liver. This new device could offer patients a quick, affordable, portable option instead of requiring visits to imaging centers for MRI scans.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have an ultrasound exam using the new Hepatoscope device, which is a portable ultrasound system. This exam will be done alongside your already-scheduled MRI or other imaging tests — you won't need extra hospital visits. The ultrasound takes measurements of your liver's fat content, and researchers will compare these results to your other imaging to see how accurate the new device is.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France